Epoprostenol Sodium
Spezifikationen
61849-14-7CAS-Nummer
263-273-7EG-Nummer
sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoateIUPAC-Name
C20H31NaO5Chemische Formel
374.4 g/molMolekulargewicht
Epoprostenol sodium; 61849-14-7; Prostacyclin sodium salt; Cyclo-Prostin; Sodium prostacyclin; DTXSID3046617; 4K04IQ1OF4; U-53217A; U-53,217A; DTXCID1026617; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-; RefChem:57240; 263-273-7; Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; Flolan; Prostacyclin sodium; Sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate; C20H31NaO5; sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate; Epoprostenol sodium [USAN:BAN]; NCGC00167427-01; EINECS 263-273-7; UNII-4K04IQ1OF4; U 53,217A; Epoprostenolsodium; (5Z,9?,11?,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; Epoprostenol Sodium; Flolan;; Prostaglandin X sodium; Prostaglandin I2 sodium; PROSTAGLANDIN I2 Na; CHEMBL962; Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate; SCHEMBL41344; Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; BML1-F10; orb1707331; Prostaglandin I2 (sodium salt); EX-A7849M; EPOPROSTENOL SODIUM [JAN]; 4UA76; EPOPROSTENOL SODIUM [USAN]; HMS1361K18; HMS3648L14; EPOPROSTENOL SODIUM [VANDF]; EPOPROSTENOL SODIUM [MART.]; Tox21_112431; EPOPROSTENOL SODIUM [USP-RS]; EPOPROSTENOL SODIUM [WHO-DD]; PROSTACYCLIN SODIUM SALT [MI]; AKOS024457370; EBC-127030; FP27241; EPOPROSTENOL SODIUM [ORANGE BOOK]; AC-38149; CAS-61849-14-7; NS00074283; T15238; Q27259818; (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxy-prosta-5,13-dien-1-oic acid sodium; Sodium (5Z,13E,15S)-11beta,15-dihydroxy-9beta,12alpha-6,9-epoxyprosta-5,13-dien-1-oate; PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, SODIUM SALT, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-; SODIUM (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATESynonyme
Produkte, die Epoprostenol Sodium enthalten
VELETRI 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONVELETRI 0,5 MG POLVO PARA SOLUCION PARA PERFUSIONEPOPROSTENOL SUN 1,5 MG POLVO PARA SOLUCION PARA PERFUSIONVELETRI 1,5 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONVELETRI 0,5 MG POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONFLOLAN 0,5 mg POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONVELETRI 1,5 mg, poudre et solvant pour solution pour perfusionVELETRI 0,5 mg, poudre et solvant pour solution pour perfusionEpoprostenol Sodium - Zhejiang Ausun PharmaceuticalEpoprostenol Sodium - MSN LaboratoriesEpoprostenol Sodium - Sun Pharmaceutical Industries LimitedEpoprostenol Sodium - EUROAPI
Seite 1 von 2
Unternehmen, die Epoprostenol Sodium verkaufen
ML
MSN LaboratoriesIndiaZA
Zhejiang Ausun PharmaceuticalChinaSP
Sun Pharmaceutical Industries (Europe) B.V.NetherlandsJI
Janssen-Cilag International N.VSpainJC
JANSSEN CILAG INTERNATIONAL NVFrancePC
Pfizer CentreOneUnited StatesSeite 1 von 2